Generics - North America, Neurological

Filter

Current filters:

North AmericaNeurological

Popular Filters

1 to 25 of 81 results

Teva and Dr Reddy’s latest to launch generic Lunesta in USA

16-04-2014

Two more companies have debuted generic versions of the insomnia drug Lunesta (eszopiclone) tablets,…

Dainippon Sumitomo PharmaDr Reddy's LaboratoriesGenericsLunestaMarkets & MarketingNeurologicalNorth AmericaSunovion PharmaceuticalsTeva Pharmaceutical IndustriesUSA

Depomed settlements with two Gralise ANDA filers

15-04-2014

US specialty drugmaker Depomed has entered into settlement agreements with two of the three defendants…

DepomedGenericsGraliseIncepta PharmaceuticalsLegalNeurologicalNorth AmericaPatentsUSAZydus Cadila

US Judge enforces settlement deal between Mylan and Endo over generic Frova

US Judge enforces settlement deal between Mylan and Endo over generic Frova

11-04-2014

US generic major Mylan today confirmed that a federal district court has granted its request to enforce…

Endo Health SolutionsEndo PharmaceuticalsFrovaGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaPatentsUSA

Actavis in Daytrana patent settlement

Actavis in Daytrana patent settlement

20-03-2014

Generic drugs major Actavis has entered into an agreement with Noven Pharmaceuticals, a subsidiary of…

ActavisDaytranaGenericsHisamitsu PharmaLegalNeurologicalNorth AmericaNoven PharmaceuticalsPatentsUSA

Teva agrees $27.6 million settlement with US Justice Dept

Teva agrees $27.6 million settlement with US Justice Dept

12-03-2014

US subsidiaries of Israeli generics giant Teva Pharmaceutical Industries have agreed to pay the US government…

ClozapineFinancialGenericsIvaxLegalNeurologicalNorth AmericaTeva Pharmaceutical IndustriesUSA

Ranbaxy cleared to market branded generic of Aricept in Canada

Ranbaxy cleared to market branded generic of Aricept in Canada

08-01-2014

The Canadian subsidiary of Ranbaxy Laboratories has received approval to manufacture and market RAN-Donepezil…

AriceptCanadaDaiichi SankyoEisaiGenericsNeurologicalNorth AmericaRAN-DonepezilRanbaxy LaboratoriesRegulation

Sandoz in deal to market authorized generic of Shire’s Adderall XR in USA

Sandoz in deal to market authorized generic of Shire’s Adderall XR in USA

03-12-2013

UK drugmaker Shire says that its subsidiary Shire US Inc has entered into an agreement to supply an authorized…

Adderall XRGenericsLicensingNeurologicalNorth AmericaNovartisSandozShire

Mylan launches first generic Focalin XR capsules

Mylan launches first generic Focalin XR capsules

18-11-2013

US generics major Mylan has launched dexmethylphenidate hydrochloride extended-release (ER) capsules,…

Focalin XRGenericsMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaNovartis

Cadence Pharma leaps on positive patent litigation ruling

17-11-2013

The US District Court for the District of Delaware has ruled in favor of Cadence Pharmaceuticals in the…

Cadence PharmaceuticalsGenericsLegalNeurologicalNorth AmericaOfirmevPatents

Acura Pharma settles with Par and Impax over Oxecta

Acura Pharma settles with Par and Impax over Oxecta

11-10-2013

US specialty pharma firm Acura Pharmaceuticals saw its shares leap as much as 28% after it said that…

Acura PharmaceuticalsGenericsImpax LaboratoriesLicensingNeurologicalNorth AmericaOxectaPar PharmaceuticalPatents

Actavis confirms generic Suboxone sublingual film patent challenge

Actavis confirms generic Suboxone sublingual film patent challenge

09-10-2013

Actavis has filed an Abbreviated New Drug Application with the US Food and Drug Administration for buprenorphine…

ActavisGenericsNeurologicalNorth AmericaPatentsReckitt BenckiserSuboxone

Teva gains favorable court ruling in Azilect patent case

Teva gains favorable court ruling in Azilect patent case

24-09-2013

Israel-based Teva Pharmaceutical Industries has gained a favorable ruling in its patent infringement…

AzilectGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaTeva Pharmaceutical Industries

Avanir Pharma patent settlement with Wockhardt

08-09-2013

USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into a settlement agreement with the US unit…

Avanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceuticalWockhardt

Avanir Pharma settles Nuedexta patent litigation with Actavis

03-09-2013

USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) says that it has entered into a settlement agreement…

ActavisAvanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceutical

Mylan cleared to sell generic Wellbutrin XL in USA

26-08-2013

There was good news last week for US specialty and generics company Mylan (Nasdaq: MYL), when the US…

GenericsGlaxoSmithKlineMylan LaboratoriesNeurologicalNorth AmericaRegulationWellbutrin XL

Avanir agrees settlement with Sandoz over Nuedexta

14-08-2013

US drugmaker Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into a settlement agreement with Swiss…

Avanir PharmaceuticalsGenericsLicensingNeurologicalNorth AmericaNuedextaPharmaceuticalSandoz

Actavis debuts new formulations of Fioricet

30-07-2013

US generics major Actavis (NYSE: ACT) has launched new formulations of Fioricet (butalbital, acetaminophen…

AcetaminophenActavisFioricetFioricet with CodeineGenericsMarkets & MarketingNeurologicalNorth AmericaPharmaceutical

US Appeals Court overturns Copaxone patent decision

28-07-2013

Israel-based generics giant Teva Pharmaceutical Industries ((NYSE: TEVA) said on Friday (July 26) that…

CopaxoneGenericsLegalMomenta PharmaceuticalsMylan LaboratoriesNatco PharmaNeurologicalNorth AmericaNovartisPatentsPharmaceuticalSandozTeva Pharmaceutical Industries

Mylan strikes deal for Parkinson's disease drug Stalevo

26-07-2013

US generics firm Mylan (Nasdaq: MYL) and Finland-based drugmaker Orion Corp (Nasdaq OMX Helsinki: ORNAV)…

GenericsLicensingMylan LaboratoriesNeurologicalNorth AmericaOrion CorpPharmaceuticalStalevo

US appeals court reverses paroxetine order in favor of Mylan

23-07-2013

US generic drugmaker Mylan (Nasdaq: MYL) today (July 23) announced that the US Third Circuit Court of…

ApotexGenericsGlaxoSmithKlineLegalMylan LaboratoriesNeurologicalNorth AmericaparoxetinePatentsPaxil

Court ruling favors Mylan in Copaxone patent dispute

17-07-2013

A US court has dismissed claims that US generic drugmaker Mylan (Nasdaq: MYL) infringed four patents…

CopaxoneGenericsMomenta PharmaceuticalsMylan LaboratoriesNatco PharmaNeurologicalNorth AmericaPatentsSandozTeva Pharmaceutical Industries

Generic versions of Trilipix debut in USA; Mylan sued by UCB

16-07-2013

Impax Laboratories (Nasdaq: IPXL) today announced yesterday (July 15) that it is commencing shipment…

AbbVieCardio-vascularGenericsImpax LaboratoriesLegalMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaPatentsTripilixUCBVimpat

1 to 25 of 81 results

Back to top